Showing 241 - 260 results of 5,822 for search '"Journal for ImmunoTherapy of Cancer"', query time: 1.00s Refine Results
  1. 241
    Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity

    Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity by Yuan Li, Yi Zheng, Phuong Nguyen, Ting Wen, Anil G Jegga, Khalid W Kalim, Jun-Qi Yang, Mark Wunderlich, Vishnu Modur, Ashley Kuenzi Davis, Ravinder Verma, Qing Richard Lu, Fukun Guo

    Published 2022-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  2. 242
    Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial

    Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial by Dmitriy Zamarin, Taha Merghoub, Yanyun Li, Travis J Hollmann, Jason A Konner, Qin Zhou, Carol Aghajanian, Roisin E O’Cearbhaill, Aliya Holland, Rachel N Grisham, Keith L Knutson, Sven Walderich, Alexia E Iasonos, Jean M Torrisi, Lewis F Chesebrough, Autumn S Mcdonnell, Jacqueline M Gallagher, Courtney L Erskine

    Published 2020-05-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  3. 243
    Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1 immunotherapy in colon cancer

    Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1 immunotherapy in colon cancer by Dorota Wyczechowska, Amir A Al-Khami, Luis Del Valle, Augusto C Ochoa, Mohamed A Ghonim, Salome V Ibba, Abdelmetalab F Tarhuni, Youssef Errami, Hanh H Luu, Matthew J Dean, Ali H El-Bahrawy, Ilyes A Benslimane, A Hamid Boulares

    Published 2021-01-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  4. 244
    Density of tertiary lymphoid structures predicts clinical outcome in breast cancer brain metastasis

    Density of tertiary lymphoid structures predicts clinical outcome in breast cancer brain metastasis by Yuan-yuan Zhao, Bao-Rui Tao, Zhen Fan, Zun-Guo Du, Zhi-Feng Shi

    Published 2024-07-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  5. 245
    All-trans retinoic acid improves NSD2-mediated RARα phase separation and efficacy of anti-CD38 CAR T-cell therapy in multiple myeloma

    All-trans retinoic acid improves NSD2-mediated RARα phase separation and efficacy of anti-CD38 CAR T-cell therapy in multiple myeloma by Jing Guo, Xin Li, Hongmei Jiang, Jingya Wang, Zhiqiang Liu, Sheng Wang, Ying Xie, Yafei Wang, Mengqi Wang, Ziyi Peng, Yixuan Wang, Meilin Hu, Jian-Qing Mi

    Published 2023-03-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  6. 246
    1525 Initial clinical experience with chlorotoxin-redirected CAR T cells for patients with recurrent glioblastoma

    1525 Initial clinical experience with chlorotoxin-redirected CAR T cells for patients with recurrent glioblastoma by Stephen J Forman, Massimo D’Apuzzo, Renate Starr, Christine E Brown, Brenda Aguilar, Michael E Barish, Behnam Badie, Maryam Aftabizadeh, Marie Suzette Blanchard, Heini M Natri, Jamie R Wagner, Jinny A Paul, Julie A Ressler, Julie Kilpatrick, Paige Myers-McNamara, Tracey Stiller, Nicholas Benovich

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  7. 247
    A possible new pathway in natural killer cell activation also reveals the difficulty in determining human NK cell function in cancer

    A possible new pathway in natural killer cell activation also reveals the difficulty in determining human NK cell function in cancer by Robert J. Canter, William J. Murphy

    Published 2018-08-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  8. 248
    Evaluation of immune checkpoint inhibitor efficacy for solid tumors with CD274 (PD-L1 gene) amplification identified by comprehensive genomic profiling: retrospective study based on a nationwide database

    Evaluation of immune checkpoint inhibitor efficacy for solid tumors with CD274 (PD-L1 gene) amplification identified by comprehensive genomic profiling: retrospective study based o... by Hidetoshi Hayashi, Yasutaka Chiba, Kazuhiko Nakagawa, Tomohiro Nakayama, Kimio Yonesaka, Takayuki Takahama, Hisato Kawakami, Naoki Shiraishi

    Published 2024-12-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  9. 249
    Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma

    Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma by Dipongkor Saha, Samuel D Rabkin, Robert L Martuza

    Published 2020-05-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  10. 250
    959 Multiomic characterization of the tumor microenvironment in FFPE tissue by simultaneous protein and gene expression profiling

    959 Multiomic characterization of the tumor microenvironment in FFPE tissue by simultaneous protein and gene expression profiling by Hardeep Singh, Stephen Williams, Benton Veire, Alexander Hermes, Jun Chiang, Ace Santiago, Anuj Patel, David Sukovich, Lauren Gutgesell, Augusto Tentori

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  11. 251
    CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers

    CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers by Francois-Xavier Danlos, Aurélien Marabelle, Roberto Ferrara, Benjamin Besse, Lydie Cassard, Nathalie Chaput, Aude Desnoyer, Boris Duchemann, Marie Naigeon, Edouard Auclin, Jean-Mehdi Jouniaux, Lisa Boselli, Jonathan Grivel, Laura Mezquita, Caroline Caramella

    Published 2022-02-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  12. 252
    Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma

    Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma by Veronika Kremer, Marteen A. Ligtenberg, Rosa Zendehdel, Christina Seitz, Annet Duivenvoorden, Erik Wennerberg, Eugenia Colón, Ann-Helén Scherman-Plogell, Andreas Lundqvist

    Published 2017-09-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  13. 253
    ICOS-expressing CAR-T cells mediate durable eradication of triple-negative breast cancer and metastasis

    ICOS-expressing CAR-T cells mediate durable eradication of triple-negative breast cancer and metastasis by Hui Zhang, Fei Yu, Xinxin Chen, Haiyan Ye, Tao Zeng, Lixue Cao, Haojie Peng, Yanzhen Chen, Baijin Xia, Jialing Guo

    Published 2024-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  14. 254
    Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroids

    Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroids by Reinhard Dummer, Joanna Mangana, Egle Ramelyte, Achim Weber, Elias Burri, Phil F Cheng, Alia Schneider

    Published 2024-07-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  15. 255
    Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma

    Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma by Bart Neyns, Lisa Zimmer, Caroline Robert, Celeste Lebbe, Olivier Michielin, Omid Hamid, Anne Zaremba, Oliver Klein, Ruth Plummer, Joanna Mangana, Paolo A Ascierto, Katharina C Kähler, Georgina V Long, Ryan Sullivan, Grant A McArthur, Michael Weichenthal, Egle Ramelyte, Meghan J Mooradian, Douglas B Johnson, Alexander Shoushtari, Christian U Blank, Judith M Versluis, Prachi Bhave, Claudia Trojanello, Lu Si, Inderjit Mehmi, Tasnia Ahmed, Alexander M Menzies, Adnan Khattak, Severine Roy, Matteo S Carlino, Paul C Lorigan, Clara Allayous, Rachel Roberts-Thomson, Florentia Dimitriou, Kathleen Batty, Thierry Lesimple, Serigne N Lo, Alexandre Wicky, Richard Heywood, Lena Tran, Anna Stansfeld, Julia K Schwarze, Andrea Maurichi, Hui-Ling Yeoh, Mario Santinami, Andrew M Haydon

    Published 2022-07-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  16. 256
    189 Systematic evaluation of transcriptomic molecular features in advanced renal clear cell carcinoma treated with immunotherapy

    189 Systematic evaluation of transcriptomic molecular features in advanced renal clear cell carcinoma treated with immunotherapy by Jian-Guo Zhou, Benjamin Frey, Hu Ma, Chi Zhang, Udo Gaipl

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  17. 257
    Circulating CD14high CD16low intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression

    Circulating CD14high CD16low intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression by Hélène Authier, Agnès Coste, Alejandra Martinez, Gwenael Ferron, Laurence Gladieff, Mélissa Prat, Augustin Le Naour, Kimberley Coulson, Fanny Lemée, Hélène Leray, Godefroy Jacquemin, Mouna Chirine Rahabi, Léa Lemaitre, Jean-Marc Barret, Maha Ayyoub, Jean-Pierre Delord, Isabelle Tabah-Fisch, Jean-François Prost, Bettina Couderc

    Published 2020-05-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  18. 258
    Monocyte-derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy

    Monocyte-derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy by Louis Boon, Matheus H W Crommentuijn, Sjoerd T T Schetters, Laura J W Kruijssen, Yvette van Kooyk, Ernesto Rodriguez, Jan Van den Bossche, Joke M M Den Haan

    Published 2020-10-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  19. 259
    Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients

    Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients by Priyanka B. Subrahmanyam, Zhiwan Dong, Daniel Gusenleitner, Anita Giobbie-Hurder, Mariano Severgnini, Jun Zhou, Michael Manos, Lauren M. Eastman, Holden T. Maecker, F. Stephen Hodi

    Published 2018-03-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  20. 260
    107 Armoring NKG2D CAR T cells with IL-18 improves in vivo anti-tumor activity

    107 Armoring NKG2D CAR T cells with IL-18 improves in vivo anti-tumor activity by David Gilham, Thủy Nguyễn, Amélie Velghe, Hannes Iserentant, Eytan Breman, Ann-Sophie Walravens, Isabelle Gennart, Benjamin Violle, Fanny Huberty, Nancy Ramelot, Laure Twyffels, Emilie Gauthy

    Published 2021-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article

Search Tools: